DocuSign (NASDAQ:DOCU - Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02, Briefing.com reports. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company's quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.76 earnings per share. DocuSign updated its FY 2026 guidance to EPS and its Q1 2026 guidance to EPS.
DocuSign Stock Performance
DocuSign stock opened at $81.45 on Friday. The firm's 50 day moving average price is $88.06 and its two-hundred day moving average price is $79.04. The firm has a market cap of $16.45 billion, a PE ratio of 16.79, a P/E/G ratio of 6.94 and a beta of 1.02. DocuSign has a twelve month low of $48.70 and a twelve month high of $107.86.
Insider Buying and Selling at DocuSign
In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $94.77, for a total transaction of $758,160.00. Following the completion of the sale, the chief financial officer now directly owns 101,439 shares in the company, valued at $9,613,374.03. The trade was a 7.31 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Teresa Briggs sold 534 shares of the business's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the sale, the director now directly owns 7,736 shares of the company's stock, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 104,422 shares of company stock valued at $9,665,394 in the last quarter. Company insiders own 1.66% of the company's stock.
Analysts Set New Price Targets
DOCU has been the subject of several recent analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a report on Friday. Jefferies Financial Group upped their price target on shares of DocuSign from $80.00 to $95.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. HSBC reiterated a "reduce" rating on shares of DocuSign in a report on Friday, December 6th. Wells Fargo & Company raised their price objective on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Friday, December 6th. Finally, Citigroup reissued a "buy" rating on shares of DocuSign in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, DocuSign currently has an average rating of "Hold" and a consensus target price of $95.64.
Get Our Latest Report on DocuSign
DocuSign Company Profile
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.